Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04146428 · ClinicalTrials.gov registry record · NA
Evaluating BOSCC and ELSA as Outcome Measures in the Context of a JASPER Intervention Trial
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT04146428 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 84 participants.
The verdict
NCT04146428, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
Research teams in Boston University, UCLA, and Weill Cornell will recruit 90 participants in 3 years (10 participants per site per year) and evaluate JASPER, play-based intervention, using the BOSCC and ELSA-T. Participants will be randomized to receive JASPER facilitated either by a clinician or the caregiver. After 10 weeks, the participants will be evaluated using the CGI to determine if they are "responders" or "non-responders". Nonresponders will be given a mix of clinician and caregiver-facilitated JASPER and responders will remain the course for the following 10 weeks. Coding of the BOSCC and ELSA-T will be the outcome measures and change will be evaluated throughout the study.
Interventions
- BEHAVIORAL clinician-mediated JASPER
- BEHAVIORAL parent-mediated JASPER
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2021-04-27 |
| Est. Completion | 2025-10-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04146428
The ClinicalTrials.gov registry entry for NCT04146428 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which clinician-mediated JASPER is the first listed.
NCT04146428 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04146428 about?
NCT04146428 is a clinical study titled "Evaluating BOSCC and ELSA as Outcome Measures in the Context of a JASPER Intervention Trial". Research teams in Boston University, UCLA, and Weill Cornell will recruit 90 participants in 3 years (10 participants per site per year) and evaluate JASPER, play-based intervention, using the BOSCC and ELSA-T. Participants will be randomized to receive JASPER facilitated either by a clinician or th...
What is the current status of trial NCT04146428?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2021-04-27. Estimated completion is 2025-10-28.
What interventions are being tested in trial NCT04146428?
The interventions under investigation include: clinician-mediated JASPER (BEHAVIORAL), parent-mediated JASPER (BEHAVIORAL).
Who is sponsoring clinical trial NCT04146428?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.